Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTSherman who wrote (1671)	9/20/2001 7:48:18 PM
From: Oak Tree	Read Replies (2) of 2515

I don't wish C225 to be a flash in the pan - I hope it works -- problem is the facts (I am emphasizing the facts) don't show much. THey are overstated by several of the oncologists involved -- some of whom have stock and may have rose colored glasses on. All that has been shown to date is that C225 is not very toxic -- and that in studies with complicated design -- that it may make some chemotherapy work better for some patients. Those that think it will make it big generally believe that there will be lots of off label usage. That may be correct. It is also true that there will be a new miracle drugs -- with even more sexy mechanisms -- every few months -- that could knock this one off the shelf.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next